Arrowhead Research Corporation (ARWR) News

Latest headlines that mention ARWR, newest first · each headline opens the original publisher

ARWR quote
Last price
$58.16
Day change
+1.22%
Next earnings
2026-11-12 AMC

ARWR headlines

latest coverage
IBD
Arrowhead Pharmaceuticals' triglycerides-buster hit the "best-case scenario" in two studies Wednesday, leading the stock to skyrocket. The post The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High appeared first on Investor's Business Daily .
General T2ARWR

ARWR news alerts

Get an alert by email or push when a new headline mentions ARWR.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.